It Kills That: Cramer Won’t Recommend Pfizer 7% Yield
Jim Cramer declines to back Pfizer despite its 7% dividend, arguing the growth case isn’t clear. Pfizer sits near a 5...
This paragraph explains the components included in the index level and what phenomena it aggregates. It offers a concise overview to anchor deeper study.
13,672 articlesJim Cramer declines to back Pfizer despite its 7% dividend, arguing the growth case isn’t clear. Pfizer sits near a 5...
Veteran market commentator Jim Cramer signaled a shift to caution, saying funds are drying up for big tech deals. The...
New research finds america pays workers just a fraction of the country’s wealth, a share that trails most OECD peers ...
SpaceX debt is signaling risk far larger than its rating label suggests, as bond markets price in a heavier risk prem...
Amazon executed a $25 billion debt sale that drew heavy demand and extended its growth funding runway. Here are three...
In the first half of 2026, Vertiv soared as AI data centers pushed demand for cooling and power solutions. This artic...
Netflix faces renewed pressure as YouTube tightens its grip on viewers and a Warner Bros. Discovery deal clouds growt...
Public disputes can hit more than pride—they touch brand value and bank balances. Learn how chris brown avoids “inter...
In a televised address ahead of midterm campaigning, Trump pitched a sweeping SNAP reform as proof of tax-cut gains, ...
Rolex opens a tuition-free watchmaking training center in Dallas to tackle a shrinking U.S. talent pool, drawing hund...
Six crypto wallets allegedly profited about $1.2 million by betting yes on a U.S.-led strike on Iran. Regulators and ...
On a day when the market generally slipped, Plug Power captured attention with a solid quarterly report. This piece b...